About "PK repeats" [Software]

posted by Helmut Homepage – Vienna, Austria, 2010-10-21 17:51 (5297 d 15:12 ago) – Posting: # 6069
Views: 15,996

Dear Ohlbe,

just want to continue an old discussion. ;-)

❝ ❝ We still reanalyse not only the 'suspect value', but neighbouring values as well. These values serve as internal validators.


❝ Yes, I still do like this concept.


Found an interesting White Paper* from “The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis“ held 17-18 April 2008 in Montreal. See R. Phull on ‘Pharmacokinetic repeats’:

The procedure presented for performing PK repeats involved assaying the anomalous value in duplicate, so that three values are available for the sample. An additional approach presented was to assay one sample on either side of the PK repeat.

(my emphasis)
So I’m not alone – but:

Following the presentation, a comment was brought forth stating that regulatory agencies recommend against performing PK repeats; therefore, it is unwise to invest resources in the process.

In other words, don’t invest your time and money in science, but stay at the lab technician’s level of maintaining HPLC’s piping.

Plumbers of the world, unite!




Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
25 visitors (0 registered, 25 guests [including 7 identified bots]).
Forum time: 09:04 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5